Opis działalności
Vita 34 was founded in 1997 as the first private umbilical cord blood bank in Europe and, as a complete provider, offers collection logistics, preparation and storage of umbilical cord blood and cord tissue. The basis for its successful work is an outstanding position in the technological segment of cryo-preservation. Here, cells and tissue are preserved alive at some -190ºC for long periods of time, and can be used if needed in the context of medical treatment.
Zarząd & Rada nadzorcza
| CEO |
| Jakub Baran |
| Zarząd |
| Dirk Plaga, Tomasz Baran |
| Rada nadzorcza |
| Florian Schuhbauer, Steffen Richtscheid, Andreas Füchsel, Frank Köhler |
Dane firmy
| Nazwa: |
VITA 34 AG |
| Adres: |
Deutscher Platz 5,D-04103 Leipzig |
| Telefon: |
+49-341-48792-0 |
| Fax: |
+49-341-48792-20 |
| E-mail: |
info@vita34.com
|
| Internet: |
www.vita34.de |
| Przemysł: |
Biotechnologia |
| Sektor: |
Biotechnologia |
| Podsektor: |
Biotechnologia |
| Koniec roku finansowego: |
31.12 |
| Free float: |
21,93% |
| Data IPO: |
27.03.2007 |
Relacje inwestorskie
| Nazwa: |
Dr. Wolfgang Knirsch |
| Telefon: |
+49-341-48792-40 |
| Fax: |
+49-341-48792-39 |
| E-mail: |
ir@vita34group.de
|
